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Abstract
Background: It is known that repetitive, skilled, functional movement is beneficial in driving functional
reorganisation of the brain early after stroke. This study will investigate a) whether pedalling an upright, static
exercise cycle, to provide such beneficial activity, will enhance recovery and b) which stroke survivors might be
able to participate in pedalling.
Methods/Design: Participants (n = 24) will be up to 30 days since stroke onset, with unilateral weakness and
unable to walk without assistance. This study will use a modified exercise bicycle fitted with a UniCam crank. All
participants will give informed consent, then undergo baseline measurements, and then attempt to pedal. Those
able to pedal will be entered into a single-centre, observer-blinded randomised controlled trial (RCT). All
participants will receive routine rehabilitation. The experimental group will, in addition, pedal daily for up to ten
minutes, for up to ten working days.
Prognostic indicators, measured at baseline, will be: site of stroke lesion, trunk control, ability to ambulate, and
severity of lower limb paresis.
The primary outcome for the RCT is ability to voluntarily contract paretic lower limb muscle, measured by the
Motricity Index. Secondary outcomes include ability to ambulate and timing of onset and offset of activity in
antagonist muscle groups during pedalling, measured by EMG.
Discussion: This protocol is for a trial of a novel therapy intervention. Findings will establish whether there is
sufficient evidence of benefit to justify proceeding with further research into clinical efficacy of upright pedalling
exercise early after stroke. Information on potential prognostic indicators will suggest which stroke survivors could
benefit from the intervention.
Trial Registration: ISRCTN: ISRCTN45392701
Background
Therapy early after stroke
In the first few weeks after stroke, the brain is ‘primed’ for
neurological recovery in response to rehabilitation training
[1]. Indeed, Cramer [2] describes a ‘golden period’ for initi-
ating restorative therapies, starting in the first days after
onset and continuing for several weeks. However, animal
studies on early therapy are equivocal. Kozlowski et al [3]
demonstrated an increase in lesion size following early
training and proposed a ‘use-it-but-don’t-overuse-it’
strategy in this period. In contrast, Biernaskie et al [4]
found that rats given enriched rehabilitation training from
day five after an induced lesion demonstrated a marked
improvement in recovery, whilst those given similar train-
ing beginning at day 30 improved no more than controls.
Whilst animal studies provide insights into brain
changes underlying recovery, caution must be observed
in generalising to human populations. Nonetheless, clin-
ical studies do support early rehabilitation intervention
to improve outcomes [5,6]. It is also possible that, if
rehabilitation onset is delayed, patients might establish
compensatory behaviours that could impact negatively
on recovery of useful functional activity [7,8]. Addition-
ally, National Clinical Guidelines for Stroke in the
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United Kingdom advise that people with acute stroke
should be mobilised as early as possible [9]. However,
the optimal dose and type of physical therapy required
to drive useful functional reorganisation in early stroke
survivors with different clinical characteristics remains
unknown.
Repetitive, functional training early after stroke
In the first days to weeks after onset, stroke survivors can
present particular therapeutic challenges. Leg weakness is
often substantial and the ability to contract paretic mus-
cle sufficiently to be able to take part in functional, rele-
vant activity, such as walking training, can be severely
compromised. There are interventions which can be used
to improve ambulatory capacity early after stroke-includ-
ing treadmill training with and without partial body
weight support, and walking facilitated ‘hands-on’ by
therapists-but these are often time-consuming and likely
to require extensive physical assistance from one or more
members of a therapy team. The effort required from
both patient and therapist(s) is often too great to enable
more than a few repetitions of activity. This dose might
be too low for effect.
Although the number of repetitions of an activity
needed to facilitate human brain reorganisation has not
been established, animal model studies suggest that 300-
400 repetitions in a 30 minute session might be needed
[10]. Repetition of motor activity has been demonstrated
to produce changes in cortical representation maps
[10,11], and may be an important consideration in reha-
bilitation programmes.
Repetition of motor activity alone, however, is not a suf-
ficient driver to induce functional reorganisation of corti-
cal networks. Motor skill acquisition, or motor learning,
has been demonstrated to play a central role, in both ani-
mal [12] and human [13,14] studies. It has also been sug-
gested that there may be benefit from goal-directed
functional activity associated with normal afferent stimula-
tion [15]. The salience of a task is an important considera-
tion in rehabilitation programmes [7]. Indeed, current
clinical guidelines suggest that functional, task specific
activity is a key component of rehabilitation after stroke;
gait re-training to improve independence in walking is
such a functional activity and a principle goal for many
patients [9]. Such evidence might suggest that optimal
rehabilitation programmes should involve task specific
activity and increasing levels of motor skill [16].
Therapists are therefore challenged to find strategies
that enable repetitive, relevant and skilled activity in
early stroke survivors. However, it remains unknown a)
which specific physical therapies might drive brain reor-
ganisation and motor recovery and b) which patients
might respond best to which therapies.
Cycling as a potential therapeutic activity early after
stroke
Cycling is a functional activity that has potential to ben-
efit patients when used as an adjunct to therapy after
stroke [17]. It requires that agonist and antagonist mus-
cles are contracted reciprocally and in a similar pattern
to that required for walking [18]. Therefore, it is a repe-
titive muscle activity that may be beneficial in retraining
gait [19]. Indeed, pedalling may facilitate phasic, co-ordi-
nated muscle activity even in patients with severe hemi-
paresis [20]. Whilst familiar to many stroke survivors,
reciprocal pedalling is likely to require re-acquisition of
motor skill following the onset of hemiparesis.
Clinically, there is therefore potential to use static cycling
for repetitive, co-ordinated exercise training as part of
stroke rehabilitation programmes aiming to address deficits
in motor function. However, the evidence in support of
cycling interventions is preliminary. The early findings
from our ongoing systematic review are that, whilst
research into aerobic capacity after stroke has often incor-
porated a cycling paradigm [21-23], few trials have specifi-
cally evaluated the effects of cycling exercise on motor
function early after stroke. There are some indications that
cycling activity may have a positive effect on strength, reci-
procal activation of antagonistic muscle groups and balance
in stroke survivors in the sub-acute and chronic stages but
cautious interpretation of these results is required for a
number of reasons: sample sizes were relatively small (n =
24 [24]; n = 17 [20]; n = 8 [25]), exact time since stroke
onset was not specified [24] and findings related to a single
session which was not repeated over time [20].
In addition, much of this work has used a recumbent
position with a standard leg cycle ergometer for cycling
exercise [20,22,24,25]. Although suitable for cardiovascular
training, this position does not replicate the upright pos-
ture needed for walking. We propose that cycling to pro-
vide functional training of the lower limbs early after
stroke is best provided in an upright posture, in order to
maximise potential for activity in major lower limb muscle
groups, in a posture similar to walking. Indeed, muscle
activation patterns during pedalling are not fixed and are
modified according to body position [26,27] and heigh-
tened levels of activity in quadriceps and hamstrings have
been demonstrated in more upright pedalling postures
[26].
We have therefore adapted a standard exercise bike a)
to provide trunk support in an upright pedalling posture
and b) to maximise opportunities for patients with
severe lower limb weakness to pedal, with use of the
UniCam crank (UniCam Inc, Emerson, New Jersey,
USA; see instrumentation). This crank enables a reduced
circumference of the pedalling circle on the paretic side,
where position 2 (P2) is the smallest circle and position
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9 (P9) the largest (i.e normal pedalling). A preliminary
study (unpublished, 2004/05, Wandsworth UK, Local
Research Ethics Committee 03.0102) has demonstrated
that stroke survivors can: a) pedal the modified exercise
cycle for up to ten minutes with no adverse effects, and
b) tolerate the different positions of the right and left
pedals. Participants were included in this observational
study if they were at least 14 days after stroke onset,
able to sit without support for one minute, able to fol-
low a one-stage command, previously independently
mobile but now unable to mobilise and having no other
limiting disease process or pathology.
Potential prognostic indicators for therapeutic
interventions
Therapists use a wide range of clinical interventions in
their repertoire but there is little research evidence to
guide clinical decisions on which patients are likely to
respond to which therapies. Possible influential factors
include the location and size of brain lesion [28,29],
degree of motor weakness; and ability to control the
trunk to sit independently [30,31]. It is unknown
whether these factors are prognostic for obtaining bene-
fit from pedalling exercise early after stroke.
Aims
The driver for this proposed research is the hypothesis
that UniCam crank-assisted upright pedalling (UP), used
as an adjunct to conventional physical therapy, enhances
recovery of lower limb motor function in stroke survi-
vors with substantial paresis early after stroke. However,
before this hypothesis can be tested in a phase III trial,
it is important to establish whether there is sufficient
evidence of benefit (clinical efficacy) to justify proceed-
ing to subsequent larger trials and which stroke survi-
vors are most likely to be able to participate in UP
(prognostic indicators). Therefore, the aims for the cur-
rent early phase clinical research study are:
1. Clinical Efficacy
To determine whether there is sufficient evidence for
UP, balancing efficacy and potential adverse events (pain
and fatigue), to justify proceeding to subsequent larger
clinical trials; as assessed by:
a) ability to voluntarily contract paretic muscle;
b) production of reciprocal activation of antago-
nistic muscle groups during pedalling, similar to
walking;
c) timing of onset and offset of activity in
antagonist muscle groups during pedalling, simi-
lar to walking;
d) ability to walk independently.
2. Prognostic Indicators
To determine whether site of stroke lesion, trunk con-
trol ability, severity of lower limb paresis and/or ambu-
latory ability predicts ability to use UP within 30 days of
stroke onset.
Methods
Design, setting and randomisation
The proposed study will be a single centre, early phase
randomised controlled trial with observer blinding, pre-
ceded by an observational component. This design is
illustrated in figure 1.
Study procedure
All participants will undergo baseline measurement set 1
(prognostic indicators). They will then be assessed for
their ability to perform UP. Potential participants will be
taken to the treatment area and shown the cycling
equipment. If content to proceed, a hoist will be used to
seat them on the bike safely. They will be asked to
pedal slowly for one minute to familiarise themselves
with the equipment. They will then be asked to pedal
for one further minute and a visual observation of
whether they can pedal or not will be made.
Those unable to pedal and who are 31 days or more
after stroke onset will be excluded from the randomised
part of this trial. Those unable to pedal and who are 30
days or less after stroke onset will be offered further
pedalling assessments approximately every three days.
The rationale for further pedalling assessments is that,
during the first 30 days after stroke, people may experi-
ence fear of movement or emotional distress and there-
fore may need more than one experience of pedalling
within a therapeutic environment. Without repeated
opportunities for pedalling assessment some participants
may be excluded unfairly from the opportunity to parti-
cipate in UP.
Those participants able to pedal for one minute and
who are 30 days or less after stroke onset, will then
undertake baseline measures set 2 (clinical efficacy). Par-
ticipants will then be allocated randomly to either rou-
tine conventional physical therapy (CPT; control group)
or to CPT plus UP (experimental group). Randomisation
order will be generated before the trial begins by an
independent statistician, in blocks of four. Group alloca-
tion will be concealed in sequentially numbered opaque
sealed envelopes held by an independent administrator,
who is not involved in the study and will have no con-
tact with study participants. The next highest number
envelope will be opened by the independent administra-
tor in response to a telephone request from the research
therapist. After opening, envelopes will be stored
securely with the participants’ study data. Randomisa-
tion will be concealed from the independent outcome
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assessor and participants will be asked not to discuss
group allocation with the outcome assessor.
Participants will receive their allocation intervention for
up to ten minutes a day, for up to ten working days or dis-
charge from acute stroke care, whichever occurs first. On
completion of the intervention phase, participants will
undertake clinical efficacy outcome measures. Every
attempt will be made to undertake outcome measures even
if participants withdraw or are discharged before the inter-
vention phase is completed (intention to treat principle).
Yes 
Screening for study criteria 
and recruitment 
Does not meet 
study criteria 
Excluded from trial 
30 days or less after stroke 
onset given further pedalling 
assessments 
unable 
Assessment of ability to pedal 
31 days or more 
after stroke onset 
Baseline measures set 1 
(prognostic indicators) 
able 
Baseline measures set 2 
(clinical efficacy) 
Meets study criteria 
No Excluded from trial Provision of informed consent 
Approached by clinical team 
Discussion with research team 
CPT +UniCam crank-assisted 




Randomisation Excluded from 
clinical efficacy  
i i i
Figure 1 Flowchart illustrating trial design.
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Blinding
Blinding of research therapists in a therapy intervention
study is not always feasible and patients are clearly
aware that they are undergoing therapeutic interven-
tions. Consequently, for this exploration of pedalling
exercise, blinding of therapists and participants is not
possible. However, the independent assessor of clinical
outcome measures will be a trained therapist blinded to
group allocation.
Ethical considerations
Patients with communication deficit (particularly apha-
sia) are frequently excluded from stroke rehabilitation
research, despite having potential for motor benefit. In
clinical practice, however, stroke survivors with aphasia
are included in motor rehabilitation. This protocol
ensures that, providing patients can follow a single-stage
command, they can participate. Thus the results of this
trial will be applicable to clinical practice. In addition,
the protocol addresses a frequent complaint from stroke
survivors with aphasia; namely that they are not given
opportunities to be involved in research.
However, in clinical practice as well as research, it is
important to distinguish between language and cognitive
communication impairment and close liaison with the
clinical team, in particular the Speech and Language
Therapy members, is essential. Before approaching a
potential participant, the researcher will therefore dis-
cuss decision making capacity of individuals with the
clinical team. If, as a result of their assessment, the clini-
cal team’s conclusion is that communication impairment
is too great to allow an individual to give informed con-
sent, then the researcher will not approach the potential
participant. If the clinical team’s conclusion is that
informed consent is possible, albeit with the use of
enhanced communication strategies, then the researcher
will approach the potential participant.
Enhanced communication strategies will be used in
this trial. These include the use of diagrams, charting
information, repetition in a variety of ways and checking
for understanding. In addition, information sheets and
informed consent forms present information in a textual
and pictorial form.
All potential participants will be given at least 24 hours
(1 working day) to consider the information and ask ques-
tions. They will be encouraged to consult with others, out-
side of the research team, before making their decision.
All data will be encrypted and then stored on an lap
top computer by the researcher before leaving the stroke
unit. Data will be transferred onto a secure hard drive in
the research laboratory. No names will be used in any
recorded material except for the initial screening docu-
ment. Participants will be anonymised with the use of
study ID numbers.
The research study has received the approval of the
Essex 1Research Ethics Committee, UK (09/H0301/
52).
Participant inclusion criteria and recruitment process
Participants will be recruited from an acute stroke unit
and, if necessary due to pressure on stroke beds, medi-
cal wards; in a University Hospital Trust. Consultant
and therapy teams have agreed to support this trial.
Stroke survivors will initially be approached by a clini-
cal team member responsible for their care, to check that
they agree to speak to a researcher. If they agree, then a
researcher will provide potential participants with verbal
and written printed information about the trial. A video
of the procedure for getting on and off the exercise cycle
will also be available if patients wish to view it. A mini-
mum of twenty four hours (1 working day) later,
informed, signed consent will be sought. Those providing
written informed consent will be participants in this trial.
All potential participants will then be screened to check
that they meet the study criteria, which are;
• adults aged 18+
• three to thirty days following a unilateral stroke
resulting in unilateral muscle weakness with or with-
out sensory deficit;
• fit to participate as assessed by a consultant-led
medical team with resting oxygen saturations 95% or
above, resting heart rate 90 beats per minute or less
and systolic blood pressure of 100-160 mmHg
• score 0, 1 or 2 on the Functional Ambulation
Categories [32]. Clinically, this means unable to
walk; or need the help of two or more people; or
require firm continuous or intermittent support of
one person assisting with weight and balance;
• be able to sit unsupported for 30-seconds on the
edge of a bed with feet on the floor.
• have sat out of bed in a chair or wheelchair at least
once for a continual period of 15-minutes i.e. have
appropriate sitting tolerance to participate in this
cycling intervention;
• be able to follow a one-stage command i.e. suffi-
cient communication, orientation and memory to
participate in this cycling intervention;
• be independently mobile with or without an aid
prior to the index stroke;
• have no co-existing pathology contributing to
observed impairment in the paretic lower limb e.g
osteoarthritis with associated knee deformity.
Sample Size
This early phase trial is the first to use this equipment
and with this participant group. Consequently there are
no data to inform a power calculation. Sample size will
therefore be based on practical considerations, using
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estimates of the number of participants we could expect
to recruit within a 12 month time period. Using data
from our previous trials of rehabilitation earIy after
stroke [e.g [33]], we estimate a recruitment rate of two
participants per month. Therefore, the sample size has
been set at 24 participants.
Intervention and Instrumentation
All participants will receive routine conventional physi-
cal therapy (CPT) as deemed appropriate by the clinical
team. To enable replication of CPT we will record its
content and dose (minutes of therapy) with a standar-
dised schedule [34].
Control intervention
Participants allocated to the control group will receive
CPT only as described above.
Experimental Intervention
Participants allocated to the experimental group will
receive UP in addition to CPT. All experimental partici-
pants will be asked to pedal at 50 revolutions per
minute (50 rpm) at a comfortable resistance whilst
maintaining a heart rate of 85% or below their age-
predicted maximum (i.e. less than 220-age ×0.85 beats
per minute). If patients cannot achieve 50 rpm, the
research therapist will be guided by their response in
setting the maximum rpm. The mean rpm achieved will
be recorded for each participant for each intervention
session. It is anticipated that few patients this early after
stroke will immediately manage ten minutes of pedal-
ling, so the number of minutes pedalled, up to ten min-
utes, will be recorded.
Each intervention session will also involve recording:
the pedal crank setting; the degree of reciprocal activa-
tion of antagonistic muscle groups (see measurement
battery); the timing of onset and offset of activity in
antagonistic muscle groups (see measurement battery);
and the distance pedalled (m). This description of each
intervention session will allow replication of the inter-
vention and information on how to progress the inter-
vention over time in subsequent clinical trials.
Instrumentation
Maintaining sitting balance early after stroke often
requires substantial concentration and physical effort
which may limit production of selective movement in
the paretic lower limb. We have therefore adapted a
standard exercise bike so that postural support for the
trunk is provided if needed (figure 2).
We have also incorporated a UniCam crank, an
adjustment that can be applied to any commercially
available exercise bike and which enables movement of
the axis of the crank towards the centre of rotation of
the bike pedal. This thereby reduces the circumference
of the pedalling circle and reduces the required range of
movement at the knee and hip, allowing patients who
may have substantial lower limb weakness and/or limita-
tions in the range of joint movement to still pedal.
EMG data will be collected using the Datalink system
(Biometrics, UK). Muscle activity in quadriceps and
hamstring muscles for each leg will be recorded using
SX 230 (Biometrics, UK) preamplifiers. The preampli-
fiers connect to 4 analogue channels of the Datalink
subject unit, which is connected to the base unit. Infor-
mation from the base unit is collected on a lap top com-
puter running the Datalink software system. Continuous
EMG data will thus be recorded during pedalling.
The bicycle wheel is demarcated every 45 degrees
using reflective tape. As the participant pedals, an LED
sensor placed at a fixed point on the bicycle frame, is
triggered as each of the eight markers passes (figure 3).
This trigger creates a drop in voltage, creating a spike in
the software. The spikes are recorded synchronously, via
a digital channel on the Datalink subject unit, with the
EMG data. This system allows for muscle activity to be
related to the position of the pedal during the 360
degree turn.
Measurement battery
Baseline measures will be made before randomisation
and outcome measures after the intervention phase has
been completed (figure 1). Baseline measures consist of
two sets: prognostic indicators and clinical efficacy. Out-
come measures will consist of clinical efficacy measures
only.
The participant characteristics to be recorded for all
potential participants and participants will be: gender,
age (years), type and site of the stroke lesion (liaison
with medical team from scanning/clinical findings) and
time since stroke onset at entry to the trial and at each
set of study measures (days).
Clinical efficacy measures
As the primary aim of this pedalling intervention is to
enhance ability to voluntarily contract paretic muscle,
the primary measure enables assessment of impairment
level change. The Motricity Index [35] is a simple mea-
sure that can be used easily in the clinical setting to
assess the severity of motor impairment. It is also a sig-
nificant predictor of ambulatory outcomes after stroke
[30,36]. Hence it is a highly clinically relevant measure,
as it provides a direct assessment of motor function that
is correlated with eventual mobility outcomes.
To detect changes in muscle activity underlying partici-
pants’ observed performance, EMG data will be employed.
Therapists in the clinical setting frequently observe and
record alterations in, for example, muscle strength and
walking ability, but cannot accurately measure the biologi-
cal changes in muscle activity that might contribute to
changes in functional performance. In recording, proces-
sing and analysing at this level, the proposed trial will be
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able to evaluate biological change alongside frequently
used clinical measures of recovery. This change in motor
activity will be able to be detected earlier than if using
clinical measures of movement performance alone.
Regaining mobility is a key goal for stroke survivors and
independent mobility enables independence in other activ-
ities of daily living [9,30]. It is possible that, as pedalling
exercise uses similar motor control patterns to those
required for walking, UP after stroke might have a positive
effect on ambulatory function. A measure of walking ability
has therefore been included in this study. The Functional
Ambulatory Categories (FAC) [32] has demonstrated
sensitivity in stroke survivors who cannot walk at the begin-
ning of their rehabilitation period, applicable to participants
in this trial, who are not mobile at inclusion. This measure-
ment of ambulatory function provides an assessment of an
activity level change that is highly relevant after stroke and
completes a spectrum of measures for this trial from body
structure through function to activity.
Primary outcome 1. Ability to voluntarily contract pare-
tic muscle
This will be measured by the Motricity Index (MI) lower
limb section [35]. The MI is a widely used measure and
Figure 2 The modified exercise cycle.
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has established validity and reliability for use after stroke
[37]. It is an ordinal weighted scale with six measurement
levels within each of three categories for the lower limb.
The three categories are: ankle dorsiflexion, knee exten-
sion, and hip flexion. For each movement, a score of 0, 9,
14, 19, 25, or 33 is given, where 0 is no movement, 19 is
full range movement against gravity not against resistance
and 33 is normal power.
Secondary outcomes 2. Ability to walk independently
As measured by the Functional Ambulation Categories
(FAC) [32]. This scale is designed to give detail on physical
support needed by patients for walking, so has clinical
relevance, and is easy to use. It has established validity and
reliability for use after stroke [38]. It is an ordinal scale,
patients scoring from 0-5, where 0 indicates a patient who
is not able to walk or needs help of 2 therapists, and 5
indicates a patient who is independent in ambulation even
on stairs.
3. Onset and offset of EMG activity of antagonistic
muscle groups during pedalling
EMG activity will be recorded in quadriceps and ham-
string muscles for each leg. Before getting on the bike,
participants will have a small (37 mm × 18 mm) pre-
amplifier applied to the front and back of their thigh on
both sides, following skin preparation to minimise signal
interference. Electrode position is known to be a vital
factor in achieving accurate EMG information [39]. For
this study, a single researcher will place the electrodes
for each participant and for every session, using pub-
lished guidelines [40]. When the participants are posi-
tioned comfortably on the bike, the leads from the
Figure 3 Diagrammatic representation of wheel demonstrating divisions.
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pre-amplifiers will be connected as described in
instrumentation.
Resting EMG activity will be recorded as a voltage at
1,000 Hz whilst the participant’s foot is resting firmly
on a box so that the leg is still and supported with the
knee in 5-15 degrees of flexion, for 30 seconds. This will
be undertaken for each leg. EMG data (voltage) will be
collected continuously during pedalling for a minimum
of 30 seconds at approximately 50 rpm.
Baseline EMG values will be calculated from the recti-
fied, processed signal as the mean ± 3 SD (standard
deviations) during the 30 seconds baseline data collec-
tion period. Onset of activity in each of the four muscle
groups will be defined as the time point during the 360
degree turn at which EMG voltage exceeds the mean
baseline value plus 3SD for 20 consecutive data points
(20 ms). Offset of activity in each of the four muscle
groups will be defined as the time point during the 360
degree turn at which EMG voltage falls below the mean
baseline value minus 3SD for 20 consecutive data points
(20 ms). The time point for onset and offset of muscle
activity in each of the four muscle groups will also be
recorded as a function of the position of the pedal dur-
ing the 360 degree turn.
4. Reciprocal activation of antagonistic muscle
groups (muscle activity) during pedalling
Rectified EMG data for each antagonistic muscle
group will be analysed using Spearman’s correlation
coefficient. An r value of 1.0 indicates perfect positive
correlation and therefore complete co-contraction, no
reciprocal activation, of an antagonistic muscle pair. An
r value of 0 indicates no correlation and therefore no
relationship between EMG activity of an antagonistic
muscle pair. An r value of -1.0 indicates a perfect nega-
tive correlation and therefore complete reciprocal activa-
tion of antagonistic muscle groups.
Prognostic indicator measures
5. Site of stroke lesion
The location and size of stroke lesion have been
demonstrated to be a prognostic factor for functional
outcomes after stroke [28,29]. It is possible, therefore,
that this clinical factor might be linked to the ability to
take part in rehabilitation interventions. Brain lesion
location will therefore be recorded from the clinical
scan.
6. Degree of muscle weakness as measured by the
Motricity Index (see clinical efficacy measures)
7. Ambulatory Capacity as measured by the Func-
tional Ambulatory Categories (see clinical efficacy
measures)
The FAC has been found to have good predictive
validity for community ambulation after stroke (FAC ≥
4 predicts community ambulation at six months with
100% sensitivity and 78% specificity) [38]. It is proposed
that pedalling exercise might have a positive effect on
walking and thus postulated that the ability to walk
might influence the ability to pedal and respond to ped-
alling intervention.
8. Ability to control the trunk
As measured by the Trunk Control Test [37]. This is a
short, simple measure of motor loss developed for use
after stroke. Patients are asked to do four movements-
rolling to their weak side, rolling to their strong side,
sitting up from lying down and balancing in a sitting
position. Each movement is scored according to ability,
either 0, 12 or 25, leading to a total score out of 100.
Validity and reliability (comparison with Rivermead
Motor Assessment at six, twelve and eighteen weeks
post-stroke-Spearman’s rho, r= 0.70, 0.72 and 0.79
respectively; interrater reliability, Spearman’s rho, r =
0.76, p < 0.001) have been established [37].
Balance (trunk) control is highly specific to ambula-
tory control, and makes a crucial contribution to the
ability to perform activities of daily living [41]. The
Trunk Control Test has been found to be a predictor of
functional outcomes after stroke, including significant
correlation with: discharge Functional Independence
Measure (Pearson’s r = 0.738) and gait velocity (Pear-
son’s r = 0.654) [31]; and discharge walking ability
(Spearman’s rho = 0.71) [36]. It is possible, therefore,
that trunk control early after stroke might influence the
ability to perform rehabilitation activities and thus will
be assessed as a potential prognostic indicator for pedal-
ling exercise after stroke.
Adverse events
There is a small risk that for some people, UP might
lead to an “overuse” syndrome, as expressed through an
increase in pain or fatigue. We will monitor for this by
checking for participant reports of lower limb pain,
either verbal or behavioural. Intervention will cease and
an adverse event recorded if a participant demonstrates
a decrease of 2 or more minutes in ability to pedal on 2
consecutive treatment days, or a 25% reduction in mean
rpm on 2 consecutive treatment days.
Statistical Analysis
The aim of the analysis is not to definitively demonstrate
efficacy in this early phase trial. Rather the data will be
used to inform a decision on whether or not to undertake
subsequent studies of UP. Assuming a normal distribu-
tion, independent t-tests will be used to compare groups
between trial arms for follow-up measures, together with
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95% confidence intervals to inform preliminary conclu-
sions on clinical benefit. Within-group analysis will be
assessed using paired t-tests. If a normal distribution can-
not be assumed, analogous non-parametric methods will
be used.
Associations between potential prognostic indicators
and the ability to pedal will be examined using Fishers
Exact test.
Trial management
A Trial Management Group (TMG) will provide overall
supervision and ensure good conduct of the trial (i.e.
adherence to the Declaration of Helsinki). The TMG
will meet every three months during the course of this
trial. In accordance with the MRC code of good practice
in clinical trials and the CONSORT guidelines, we will
document all decisions regarding eligibility for entry,
consent giving, inclusion, exclusion and attrition. Mem-
bers of the TMG will be: the researcher (NH) and mem-
bers of the research team (VP, LS, PR, PKM). Every six
months during data collection, the TMG will include an
invited independent patients’ advocate from the clinical
stroke service.
Discussion
This protocol describes an original, two-stage early
phase trial, in which a group of early stroke survivors
will first be evaluated for their ability to pedal a modi-
fied upright exercise cycle. Those who can pedal the
cycle will then be participants in an early phase rando-
mised controlled trial of daily pedalling intervention, for
up to ten subsequent working days of their in-patient
hospital stay.
Findings from neuroimaging studies suggest that reha-
bilitation programs incorporate repetition, motor skill
acquisition and functional activity in order to optimally
drive useful cortical plasticity [e.g. [10-14]]. It has been
suggested that early rehabilitation intervention might
exploit a crucial period in which the brain is primed to
begin repair, in the first few days after stroke onset
[1,2]. Therapists are therefore challenged to find rehabi-
litation strategies incorporating these underlying princi-
ples. Cycling provides a paradigm through which such
activity might be achieved even in early stroke partici-
pants with severe weakness. For this trial, a prototype
upright exercise cycle has been developed to enable
such patients to experience bilateral pedalling motion.
The locomotor strategies employed during cycling are
akin to those used in ambulation [18] and our exercise
cycle also incorporates adaptations to allow stroke survi-
vors with considerable weakness to attempt to pedal in
an upright posture, similar to walking.
Whilst evidence exists correlating clinical aspects of
stroke to functional outcomes [e.g. [28-30]], prognostic
information on what factors might influence the ability
to take part in specific rehabilitation activities has yet to
be established. This information has the potential to
inform the design of future research and provide indica-
tors to clinicians about which patients might best take
part in which activities. The current trial will record
four potential prognostic indicators-site of lesion, trunk
control, paretic leg motor function and walking ability-
before participants attempt to use the equipment; links
to the ability to pedal the pedalling activity will be ana-
lysed and contribute to clinical conclusions and inform
future research. For this novel aspect of the study, selec-
tion of potential indicators was based on those factors
previously demonstrated to correlate to functional out-
comes after stroke.
Some exploratory studies have investigated the potential
clinical efficacy of pedalling exercise after stroke [20,24,25]
but the early findings of our systematic review (in pro-
gress) suggest that no trial has evaluated upright pedalling
in a group of stroke survivors within one month of stroke
onset. The potential challenges that early stroke survivors
might face in taking part in this activity, such as safely sit-
ting in an upright posture and taking part in repetitive
exercise, have been addressed: firstly by using a modified
exercise cycle, and secondly, by ensuring that physiological
parameters and evidence of fatigue are monitored and
recorded by the research team.
It is possible that our results might indicate none of the
prognostic indicators are linked to the ability to pedal,
and/or clinical efficacy of the intervention is not demon-
strated. If this is the case, the risk of wasting valuable
research resources on larger-scale trials, using the current
indicators and measures, is minimised. However, interpre-
tation of findings, whether negative or positive, will reflect
the small sample size and early phase nature of this work.
A further novel aspect is that this study of pedalling
exercise incorporates biological level measures, alongside
more frequently used clinical, functional measures. EMG
data from quadriceps and hamstrings will be recorded at
baseline and outcome as well as at each pedalling ses-
sion, providing evidence of any change at a biological
level that might contribute to, and underpin, possible
changes in functional measures. Using sessional EMG
recordings will also allow analysis of whether pedalling
is being achieved by the unaffected leg propelling the
crank i.e with the use of compensatory strategies, or
whether there are changes in recordable activity in the
affected leg suggestive of recovery.
The control group will undergo conventional therapy
only, and this will be quantified on a standardised treat-
ment schedule, allowing for comparisons of amount and
type of therapy across trial arms. Concern has been
expressed that reporting of research into complex inter-
ventions often lacks sufficient detail on comparators
Hancock et al. Trials 2011, 12:68
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[42]. The use of careful recording of conventional ther-
apy in this trial will go some way towards addressing
these concerns and might provide important informa-
tion for potential dose-matching in later phase work.
This trial is being carried out in an acute stroke unit,
and uses portable EMG equipment so that all trial mea-
sures can be taken on site. This enables participants to
take part in an active rehabilitation setting and hence
exploration of the feasibility of the use of the modified
bicycle in a busy therapeutic environment; and ensures
close collaboration between clinical and research teams
for the duration of data collection.
In summary, the proposed novel, early phase research
will increase knowledge of prognostic indicators for, and
clinical efficacy of, upright pedalling exercise early after
stroke. It will provide essential information for the
design of subsequent trials.
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